Japan· JP-2190029D1041
炭酸ランタン水和物
A lanthanum carbonate product containing 炭酸ランタン水和物, registered in Japan by 日本ケミファ, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Lanthanum carbonate is registered in 11 of 19 countries.
Countries holding a registration under ATC V03AE03 (lanthanum carbonate), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 6 of them publish a price we can compare per daily dose
Lanthanum carbonate · ATC V03AE03
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
Price per daily dose
What a daily dose of lanthanum carbonate costs, country by country.
Normalised to the WHO defined daily dose (2.25 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Lanthanum carbonate · price per daily dose (2.25 g)
USD · FX 28 Sept 2026
- CH Switzerland$9.20
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- 炭酸ランタン水和物
- Manufacturer
- 日本ケミファ
- Country
- Japan (JP)
- ATC code
- V03AE03
- ATC class
- Lanthanum carbonate
- Defined daily dose
- 2.25 g, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
75 interactions on record for lanthanum carbonate.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Lanthanum carbonate · interactions on record
75 records
- 2 severe
- 73 moderate
Most severe, free to view
- ErdafitinibL01EN01severe
- ErdafitinibL01EX16severe
- DicoumarolB01AA01moderate
- WarfarinB01AA03moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Lanthanum carbonate in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesFosrenolTakeda Pharmaceuticals America, Inc.
- SwedenFosrenol 1000 mg Oralt pulverTakeda Pharmaceuticals International AG Ireland Branch
- United KingdomFosrenol 1000mg chewable tabletsTakeda UK Ltd
- FranceFOSRENOL 1000 mg, comprimé à croquerTAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)
- NorwayFosrenolTakeda Pharmaceuticals International AG Ireland Branch
- IrelandFoznol 1000 mg Chewable TabletsPCO Manufacturing Ltd.
- BelgiumFosrenol 1000 mgTakeda Pharmaceuticals International Ireland Branch
- FinlandFosrenolTakeda Pharmaceuticals International AG Ireland Branch
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Fosrenol
- Belgium · Fosrenol
- Cyprus · Fosrenol
- Czechia · Fosrenol
- Germany · Fosrenol, Lanthan Mylan
- Denmark · Fosrenol, Lanthanum Orifarm
- Estonia · Calafos, Fosrenol
- Spain · Fosrenol
- Finland · Fosrenol
- France · Fosrenol, Lanthane Viatris
- United Kingdom (Northern Ireland) · Fosrenol, Lanthanum Mylan
- Greece · Fosrenol
- Croatia · Lantan
- Hungary · Fosrenol
- Ireland · Foznol
- Iceland · Fosrenol
- Italy · Foznol
- Lithuania · Calafos, Fosrenol
- Luxembourg · Fosrenol
- Latvia · Calafos, Fosrenol
- Malta · Foznol
- Netherlands · Fosrenol, Lanthaan Viatris
- Norway · Fosrenol, Lanthanum Orifarm
- Sweden · Fosrenol, Lanthanum Orifarm
- Slovenia · Fosrenol
- Slovakia · Fosrenol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c8180f71-45f2-4c42-b3cb-d6d06a0c70d5 GET /v1/drugs/c8180f71-45f2-4c42-b3cb-d6d06a0c70d5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "250mg1包",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2190029D1041",
"category": "内用薬",
"price_yen": 29,
"generic_name": "炭酸ランタン水和物",
"product_name_jp": null,
"therapeutic_class": "2190",
"transitional_expiry": null
}See everything about lanthanum carbonate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.